TriSalus Life Sciences, Inc. (TLSI)

NASDAQ

$5.00

+$0.06 (1.21%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$4.88$5.13

Open $4.99

52 Week Range

$3.42$7.95

Previous Close $4.94

Market Cap162.71M

Volume156.97K

Avg Volume176.01K

P/E (TTM)-5.45

EPS (TTM)$-0.92

Dividend / YieldN/A

Dividend StreakN/A

About TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.

Company Info

SectorHealthcare

IndustryMedical - Devices

CEOMary T. Szela

Employees110

Websitetrisaluslifesci.com

Trading Information

Open

$4.99

Previous Close

$4.94

Day High

$5.13

Day Low

$4.88

52 Week High

$7.95

52 Week Low

$3.42